Palantir a high-risk investment with ’a one-of-a-kind growth and margin model’
Henry Scott Robert, a director at Nexgel , Inc. (NASDAQ:NXGL), recently sold a portion of his holdings in the company. According to a filing with the Securities and Exchange Commission, Robert sold 3,000 shares of Nexgel common stock on March 10, 2025. The shares were sold at an average price of approximately $2.8737, resulting in a total transaction value of $8,621. The transaction comes as the company, currently valued at $21.2 million, has shown strong revenue growth of 90.57% over the last twelve months, despite challenges with profitability.
The shares were sold under a Rule 10b5-1 trading plan, which allows insiders to set up a predetermined schedule for selling stocks. These shares were initially purchased by Robert on the open market in September 2022 and were not part of Nexgel’s recent registered direct offerings. According to InvestingPro analysis, the company is currently trading above its Fair Value, with investors anticipating the next earnings report on March 26, 2025.
Following this transaction, Robert holds 138,053 shares of Nexgel. For deeper insights into NXGL’s financial health, valuation metrics, and expert analysis, access the comprehensive Pro Research Report available exclusively on InvestingPro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.